Mirxes Holding Co - Public Comps and Valuation Multiples

Mirxes Holding Co Overview

About Mirxes Holding Co

Mirxes Holding Co Ltd is a miRNA technology company that is making diagnostic solutions for the screening of diseases accessible across its key markets in Asia, including Singapore and China. It has one Core Product (namely, GASTROClearTM), two other commercialized products (namely, LUNGClearTM and FortitudeTM), and six product candidates at the pre-clinical stage, as illustrated in the chart below. GASTROClearTM, its Core Product, is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. The company generates the majority of its revenue from Singapore.

Founded

2020

HQ

Employees

352

Website

mirxes.com

Sectors

Genomics & Personalized Medicine

Financials

Last FY Revenue $2.6M

Last FY EBITDA -$9.1M

EV

$1.8B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Mirxes Holding Co Financials

See Mirxes Holding Co valuation multiples based on analyst estimates

Mirxes Holding Co P&L

In the most recent fiscal year, Mirxes Holding Co reported revenue of $2.6M and EBITDA of -$9.1M.

Mirxes Holding Co expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Mirxes Holding Co valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$2.6M	XXX	XXX	XXX
Gross Profit	XXX	$1.1M	XXX	XXX	XXX
Gross Margin	XXX	44%	XXX	XXX	XXX
EBITDA	XXX	-$9.1M	XXX	XXX	XXX
EBITDA Margin	XXX	-348%	XXX	XXX	XXX
EBIT	XXX	-$8.6M	XXX	XXX	XXX
EBIT Margin	XXX	-332%	XXX	XXX	XXX
Net Profit	XXX	-$11.8M	XXX	XXX	XXX
Net Margin	XXX	-455%	XXX	XXX	XXX
Net Debt	XXX	$2.4M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Mirxes Holding Co including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Mirxes Holding Co achieved $2.6M in revenue and -$9.1M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$2.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$1.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	43.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	-$9.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	-348.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	-$8.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	-331.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	-$11.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	-455.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$2.4M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Mirxes Holding Co

This financial data table provides comprehensive performance metrics for Mirxes Holding Co, a company based in Hong Kong. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Mirxes Holding Co reported $2.6M in total revenue.
Fiscal year EBITDA was -$9.1M.
The company maintained a gross profit margin of 43.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was -348.1%.
Net profit margin reached -455.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Mirxes Holding Co. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Mirxes Holding Co Stock Performance

Mirxes Holding Co has current market cap of HKD 15.0B (or $1.9B), and EV of HKD 14.3B (or $1.8B).

Market Cap Evolution

Mirxes Holding Co Stock Data

As of September 17, 2025, Mirxes Holding Co's stock price is HKD 54 (or $7).

See Mirxes Holding Co trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.8B	$1.9B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Mirxes Holding Co Valuation Multiples

Mirxes Holding Co's trades at 707.1x EV/Revenue multiple, and -203.1x EV/EBITDA.

See valuation multiples for Mirxes Holding Co and 15K+ public comps

Mirxes Holding Co Financial Valuation Multiples

As of September 17, 2025, Mirxes Holding Co has market cap of $1.9B and EV of $1.8B.

Equity research analysts estimate Mirxes Holding Co's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Mirxes Holding Co's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.9B	XXX	$1.9B	XXX	XXX	XXX
EV (current)	$1.8B	XXX	$1.8B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	707.1x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-203.1x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-213.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-162.5x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-454.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Mirxes Holding Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Mirxes Holding Co Margins & Growth Rates

Mirxes Holding Co's revenue per employee in the last FY averaged $7K, while opex per employee averaged $28K for the same period.

Mirxes Holding Co's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Mirxes Holding Co's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Mirxes Holding Co and other 15K+ public comps

Mirxes Holding Co Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	-348%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$7K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$28K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	38%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	94%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	376%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial